The single-dose Johnson & Johnson vaccine developed by pharmaceutical company Janssen may be approved in March, with the general public starting vaccinations towards the beginning of May.
This was revealed by Health Minister Chris Fearne during XTRA on TVM, going on to state that the approval of said vaccine will push forward Malta’s inoculation timeline considerably.
Malta has ordered 250,000 of this vaccine, of which trials have revealed that the vaccine has 66% overall efficacy but it is 85% effective against severe COVID-19 cases.
#MaltaDaily